Stay updated on BCG & ALT-803 Combo in BCG Unresponsive Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the BCG & ALT-803 Combo in BCG Unresponsive Bladder Cancer Clinical Trial page.

Latest updates to the BCG & ALT-803 Combo in BCG Unresponsive Bladder Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedNew revision v3.4.2 was added and previous revision v3.4.1 was removed, indicating a page-level system update; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check21 days agoChange DetectedNew site-wide notice about government funding and NIH operating status appears, and the history now shows Revision: v3.4.1 replacing the previous v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check28 days agoChange DetectedThe page history UI now includes a glossary toggle, green highlights for additions, red highlights for deletions, and an updated revision label to v3.4.0. These are cosmetic UI updates that do not affect the underlying study data or its interpretation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check35 days agoChange DetectedStudy Record Versions, Record History, and Study Details have been removed, along with Save and Download options, eliminating access to past versions and related metadata. This reduces the ability to view or compare historical changes on the record.SummaryDifference13%

- Check42 days agoChange DetectedRevision number changed from v3.3.3 to v3.3.4. No visible changes to study data or page content.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision: v3.3.3 was added to the history, and the HHS Vulnerability Disclosure and Revision: v3.3.2 were removed from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to BCG & ALT-803 Combo in BCG Unresponsive Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BCG & ALT-803 Combo in BCG Unresponsive Bladder Cancer Clinical Trial page.